Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. LLY
2. DAVA
3. MONC:IM
4. MONRY
5. NYXH
6. PNR
7. ONON
8. IAUX
9. KKR
10. VICR

Go back to Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)
DYNEGY, Inc. (NASDAQ: DYN) Delayed: 17.12 --0 (-0%)
Previous Close $17.12    52 Week High $22.01 
Open $17.12    52 Week Low $7.01 
Day High $17.12    P/E N/A 
Day Low $17.12    EPS $0.00 
Volume 18